AMN Healthcare Services (AMN) Q4 2023 earnings summary

Executive summary

• 2023 results reflected the largest cyclical reset in healthcare staffing demand; Q4 revenue was $818.3M, down 27% YoY, with results consistent with expectations.

• Technology investment and an integrated sales platform advanced; candidate traffic and applicants exceeded expectations, and a largest MSP client win since 2019 was signed.

• Strength in language services and organic locum tenens partly offset continued softness in travel nursing and vendor management systems.

Financial highlights

• Q4 revenue was $818.3M, gross profit $260.9M, net income $12.5M, GAAP diluted EPS $0.33, and adjusted diluted EPS $1.32.

• Q4 net income fell 85% YoY; adjusted EBITDA was $104.0M, down 40% YoY.

• FY23 revenue was $3.789B, net income $210.7M, GAAP diluted EPS $5.36, adjusted diluted EPS $8.21, and adjusted EBITDA $579.1M.

• FY23 revenue declined 28% YoY; net income declined 53% and adjusted EBITDA declined 32%.

Outlook and guidance

• Q1 2024 revenue guidance: $810M–$830M; gross margin 31.0%–31.5%; SG&A 21.0%–21.5% of revenue; operating margin 4.2%–4.9%; adjusted EBITDA margin 11.2%–11.7%.

• Q1 revenue expected down 26%–28% YoY: Nurse and Allied down 36%–38%, Physician and Leadership up 11%–14%, and Technology and Workforce down 18%–20%.